Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Venous Thromboembolism × Dalteparin × CNS × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Classical hematology 15 Gastrointestinal 2 Thoracic 1 Other 1 CNS 1

Conditions

Venous Thrombosis 1 Venous Thromboembolism 1 Pulmonary Embolism 1 Gliosarcoma 1 Glioma 1 Glioblastoma 1 Central Nervous System Neoplasms 1 Brain Neoplasms 1

Interventions

Tinzaparin 1 Rivaroxaban 1 Long-Term Synaptic Depression 1 Dalteparin 1 Aspirin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00135876 2007-04-27

Dalteparin Low Molecular Weight Heparin for Primary Prophylaxis of Venous Thromboembolism in Brain Tumour Patients

Ontario Clinical Oncology Group (OCOG)

Phase 3 Completed

CNSClassical hematology

Brain Neoplasms, Glioma, Pulmonary Embolism, Venous Thrombosis, Venous Thromboembolism

Data powered by HemOnc (CC BY 4.0) Colophon ⚡